These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 21795477

  • 1. The tumor suppressive microRNA miR-218 targets the mTOR component Rictor and inhibits AKT phosphorylation in oral cancer.
    Uesugi A, Kozaki K, Tsuruta T, Furuta M, Morita K, Imoto I, Omura K, Inazawa J.
    Cancer Res; 2011 Sep 01; 71(17):5765-78. PubMed ID: 21795477
    [Abstract] [Full Text] [Related]

  • 2. Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer.
    Kozaki K, Imoto I, Mogi S, Omura K, Inazawa J.
    Cancer Res; 2008 Apr 01; 68(7):2094-105. PubMed ID: 18381414
    [Abstract] [Full Text] [Related]

  • 3. Potential of tumor-suppressive miR-596 targeting LGALS3BP as a therapeutic agent in oral cancer.
    Endo H, Muramatsu T, Furuta M, Uzawa N, Pimkhaokham A, Amagasa T, Inazawa J, Kozaki K.
    Carcinogenesis; 2013 Mar 01; 34(3):560-9. PubMed ID: 23233740
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Downregulation of microRNA 99a in oral squamous cell carcinomas contributes to the growth and survival of oral cancer cells.
    Yan B, Fu Q, Lai L, Tao X, Fei Y, Shen J, Chen Z, Wang Q.
    Mol Med Rep; 2012 Sep 01; 6(3):675-81. PubMed ID: 22751686
    [Abstract] [Full Text] [Related]

  • 6. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma.
    Furuta M, Kozaki KI, Tanaka S, Arii S, Imoto I, Inazawa J.
    Carcinogenesis; 2010 May 01; 31(5):766-76. PubMed ID: 19843643
    [Abstract] [Full Text] [Related]

  • 7. NDRG2 is a candidate tumor-suppressor for oral squamous-cell carcinoma.
    Furuta H, Kondo Y, Nakahata S, Hamasaki M, Sakoda S, Morishita K.
    Biochem Biophys Res Commun; 2010 Jan 22; 391(4):1785-91. PubMed ID: 20045673
    [Abstract] [Full Text] [Related]

  • 8. miR-370 modulates insulin receptor substrate-1 expression and inhibits the tumor phenotypes of oral carcinoma.
    Chang KW, Chu TH, Gong NR, Chiang WF, Yang CC, Liu CJ, Wu CH, Lin SC.
    Oral Dis; 2013 Sep 22; 19(6):611-9. PubMed ID: 23231387
    [Abstract] [Full Text] [Related]

  • 9. MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta.
    Tsukamoto Y, Nakada C, Noguchi T, Tanigawa M, Nguyen LT, Uchida T, Hijiya N, Matsuura K, Fujioka T, Seto M, Moriyama M.
    Cancer Res; 2010 Mar 15; 70(6):2339-49. PubMed ID: 20215506
    [Abstract] [Full Text] [Related]

  • 10. Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling.
    Yang MH, Lin BR, Chang CH, Chen ST, Lin SK, Kuo MY, Jeng YM, Kuo ML, Chang CC.
    Oncogene; 2012 May 10; 31(19):2401-11. PubMed ID: 21927029
    [Abstract] [Full Text] [Related]

  • 11. miR-181a shows tumor suppressive effect against oral squamous cell carcinoma cells by downregulating K-ras.
    Shin KH, Bae SD, Hong HS, Kim RH, Kang MK, Park NH.
    Biochem Biophys Res Commun; 2011 Jan 28; 404(4):896-902. PubMed ID: 21167132
    [Abstract] [Full Text] [Related]

  • 12. MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation.
    Lee KH, Chen YL, Yeh SD, Hsiao M, Lin JT, Goan YG, Lu PJ.
    Oncogene; 2009 Sep 24; 28(38):3360-70. PubMed ID: 19597470
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA-186 serves as a tumor suppressor in oral squamous cell carcinoma by negatively regulating the protein tyrosine phosphatase SHP2 expression.
    Cai Z, Hao XY, Liu FX.
    Arch Oral Biol; 2018 May 24; 89():20-25. PubMed ID: 29407635
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Rictor and integrin-linked kinase interact and regulate Akt phosphorylation and cancer cell survival.
    McDonald PC, Oloumi A, Mills J, Dobreva I, Maidan M, Gray V, Wederell ED, Bally MB, Foster LJ, Dedhar S.
    Cancer Res; 2008 Mar 15; 68(6):1618-24. PubMed ID: 18339839
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The PTEN-AKT-mTOR/RICTOR Pathway in Nasal Natural Killer Cell Lymphoma Is Activated by miR-494-3p via PTEN But Inhibited by miR-142-3p via RICTOR.
    Chen HH, Huang WT, Yang LW, Lin CW.
    Am J Pathol; 2015 May 15; 185(5):1487-99. PubMed ID: 25907832
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.